Back

Validation of cardiac magnetic resonance T1 mapping in cardiac amyloidosis

28 August 2017 (17:51 - 18:00)
Organised by:
Congress Presentation Part of: CMR tissue characterisation in myocardial disease Cardiovascular Magnetic Resonance (CMR) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Franz Duca

Medical University of Vienna, Vienna (Austria)

9 More presentations in this session

Presentation thumbnail
MRI prospective survey on heart and liver iron and cardiac function in thalassemia major patients treated with Deferasirox versus Deferiprone and Desferrioxamine in monotherapy
Doctor A. Pepe (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Longitudinal prospective CMR study in pediatric thalassemia major patients
Doctor A. Pepe (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Cardiac manifestation in wilson disease. The CARMA Wilson study. A comprehensive clinical and cardiac imaging trial
Doctor S. Quick (Chemnitz, DE)
Abstract Slides Video
Presentation thumbnail
Congenital hypertrophic cardiomyopathy with genetic mutations is highly associated with left ventricular myocardial fibrosis and larger right ventricle (TW-HCM study)
Doctor C. Chen (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Long term prognostic value of Cardiac Magnetic Resonance parameters in left ventricular non-compaction
Doctor A. Pepe (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
CMR tissue characterisation in myocardial disease

The Event

Event poster

ESC Congress 2017

28 August 2017 17:51 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis in patients with heart failure
11 December 2025
thumbnail
Congress Presentation
Q&A
31 August 2025
thumbnail
Congress Presentation
Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping
22 May 2023
thumbnail
Webinar
The role of cardiac imaging for assessment of specific patient populations, according to new 2022 ESC Guidelines on Cardio-Oncology.
13 January 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources